Thu, January 30, 2025
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial selling of CytoDyn Inc. in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial selling of Evaxion Biotech A/S in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial .. g of Dogwood Therapeutics, Inc. in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial selling of Vincerx Pharma, Inc. in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial selling of Bakkt Holdings, Inc. in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial .. g of Echo Defense Projects Inc. in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial selling of BioAdaptives, Inc. in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial selling of Tapinator, Inc. in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial .. hnology Venture Company Limited in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial .. lling of Alpha Tau Medical Ltd. in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial .. hium Resource & Technology Ltd. in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial .. of NeuroSense Therapeutics Ltd. in recent trading
[ Thu, Jan 30th ]: WOPRAI
As of Jan 30th, 2025, there has been substantial selling of in recent trading
[ Thu, Jan 30th ]: Investopedia
Is Warren Buffett Right That the Stock Market Is Like a Casino? What Investors Need To Know
Wed, January 29, 2025
[ Wed, Jan 29th ]: MSN
International Paper Company (IP): Investing in Renewable Packaging Innovation
[ Wed, Jan 29th ]: MSN
UPS's SWOT analysis: global logistics giant navigates shifting stock landscape
[ Wed, Jan 29th ]: MSN
DeepSeek and AI's Efficiency Era
[ Wed, Jan 29th ]: MSN
Why Novo Nordisk A/S (NVO) Is the Best Blue Chip Stock to Buy Under $100?
[ Wed, Jan 29th ]: MSN
Looking for a bargain? 4 ways to tell if a stock is undervalued
[ Wed, Jan 29th ]: MSN
Investing Lessons from Mark Cuban Anyone Can Use
[ Wed, Jan 29th ]: Kiplinger
Stock Market Today: Stocks Jump Around on Fed Day
[ Wed, Jan 29th ]: AOL
3 ETFs Every Baby Boomer Should Buy and Hold Forever
[ Wed, Jan 29th ]: MSN
US stocks, Nvidia shares steady after Chinese AI shock
[ Wed, Jan 29th ]: MSN
Retire Rich With 2 Resilient Growth Stocks
[ Wed, Jan 29th ]: Kiplinger
ASML Stock Remains a Strong Buy After Earnings
[ Wed, Jan 29th ]: MSN
5 Building Products Stocks Navigating Industry Challenges
[ Wed, Jan 29th ]: MSN
Cantor Fitzgerald sees upside in select biotech stocks
[ Wed, Jan 29th ]: MSN
Mutual Funds: These 7 large-cap funds gave high returns in the past 10 years. Do you own any?
[ Wed, Jan 29th ]: AOL
Ask the experts: I just got married. What investing decisions should my spouse and I consider?
[ Wed, Jan 29th ]: bnnbloomberg
Goldman Strategists Say Tech Selloff Was No Bear Market Signal
[ Wed, Jan 29th ]: MSN
The Secret to Picking Top-Performing US Stocks
[ Wed, Jan 29th ]: Oregonian
Roth IRA vs. brokerage account: What's the difference?
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of OSK at $96 .. 6, after crossing above the $95.793 Trigger Price
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of OCFC at $1 .. 9, after crossing above the $18.477 Trigger Price
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of OCEL at $2 .. 85, after crossing above the $0.023 Trigger Price
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of NATR at $1 .. 2, after crossing above the $14.887 Trigger Price
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of HTBK at $9 .. 69, after crossing above the $9.673 Trigger Price
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of GRNT at $6 .. 55, after crossing above the $6.234 Trigger Price
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of CZNC at $2 .. 9, after crossing above the $21.453 Trigger Price
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of CDAY at $7 .. 2, after crossing above the $72.277 Trigger Price
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of BKYI at $1 .. 464, after crossing above the $1.45 Trigger Price
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of BKD at $4.93, after crossing above the $4.929 Trigger Price
[ Wed, Jan 29th ]: WOPRAI
Short squeeze is starting in shares of ALGT at $1 .. 9, after crossing above the $103.14 Trigger Price
[ Wed, Jan 29th ]: AOL
I'm 65, single and just inherited $420,000 from m .. passed away. How do I make sure this money lasts?
[ Wed, Jan 29th ]: MSN
The Smartest Growth Stocks to Buy With $1,000 Right Now
[ Wed, Jan 29th ]: ThePrint
5 Reasons to Consider Bajaj Finserv Flexi Cap Fund for your Portfolio in 2025
[ Wed, Jan 29th ]: WOPRAI
As of Jan 29th, 2025, there has been substantial selling of DigiAsia Corp. in recent trading
[ Wed, Jan 29th ]: WOPRAI
As of Jan 29th, 2025, there has been substantial .. Markforged Holding Corporation in recent trading

Cantor Fitzgerald sees upside in select biotech stocks

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. gerald-sees-upside-in-select-biotech-stocks.html
  Print publication without navigation Published in Stocks and Investing on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, Cantor Fitzgerald highlighted a positive outlook despite broader market uncertainties.
The article from MSN Money discusses Cantor Fitzgerald's optimistic outlook on certain biotech stocks, highlighting potential growth opportunities within the sector. The investment firm has identified several biotech companies that they believe are undervalued and poised for significant upside due to upcoming catalysts such as clinical trial results, FDA approvals, and strategic partnerships. The article mentions specific stocks like Sarepta Therapeutics, Alnylam Pharmaceuticals, and Intellia Therapeutics as having strong potential due to their innovative therapies in gene editing and rare disease treatments. Cantor Fitzgerald's analysis suggests that these companies could see substantial stock price increases if their developmental milestones are met, offering investors a chance to capitalize on the biotech sector's volatility and innovation.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/other/cantor-fitzgerald-sees-upside-in-select-biotech-stocks/ar-AA1y4j7H ]